Wachtell, Lipton, Rosen & Katz has advised AbbVie Inc. Davis Polk & Wardwell has advised the underwriters. AbbVie Inc. announced the pricing of a registered public...
AbbVie Prices $10 Billion Senior Notes Offering to Support Apogee Therapeutics Acquisition
AbbVie Announces $8 Billion Public Offering of Senior Unsecured Notes
Wachtell, Lipton, Rosen & Katz has served as legal advisor to AbbVie, Inc. Davis Polk has advised the representatives of the underwriters. AbbVie, Inc. priced a...
AbbVie Acquires Gilgamesh’s Lead Antidepressant Program for Up to $1.2 Billion
Covington & Burling LLP has advised AbbVie, and Ropes & Gray LLP have advised Gilgamesh Pharmaceuticals. AbbVie has entered into a definitive agreement to acquire the...
AbbVie Acquires Capstan Therapeutics in $2.1 Billion Deal to Expand Immunotherapy Portfolio
Ropes & Gray has advised AbbVie on the transaction, and Cooley has advised Capstan Therapeutics AbbVie has announced the acquisition of Capstan Therapeutics in a transaction...
Xilio Therapeutics’ $2.1 Billion Collaboration With AbbVie
Latham & Watkins advised AbbVie on the transaction, and Ropes & Gray advised Xilio Therapeutics. Xilio Therapeutics (Nasdaq: XLO) announced a strategic collaboration and option agreement...
AbbVie’s $1.4 Billion Acquisition of Aliada Therapeutics
Covington & Burling advised AbbVie on the transaction, and Fenwick & West advised Aliada Therapeutics. AbbVie (NYSE: ABBV), a pharmaceutical firm, announced it has entered into...
In re Bystolic Antitrust Litigation
White & Case LLP has successfully led AbbVie Inc. and several other pharmaceutical companies, as co-defendants, to secure a dismissal with prejudice in the case. In...
AbbVie’s $15 Billion Unsecured Notes Offering
Wachtell, Lipton, Rosen & Katz served as legal advisor to AbbVie on the transaction. AbbVie Inc. issued and sold $15.0 billion aggregate principal amount of senior...
AbbVie’s Collaboration with Umoja Biopharma
Ropes & Gray advised AbbVie on the deal. AbbVie (NYSE: ABBV), and Umoja Biopharma (Umoja) Umoja Biopharma announced two exclusive option and license agreements to develop multiple in-situ...
AbbVie’s Acquisition of Cerevel Therapeutics
Kirkland & Ellis advised AbbVie, Latham & Watkins advised Cerevel Therapeutics, Skadden advised Centerview partners LLC, as financial advisor to Cerevel Therapeutics in the transaction. AbbVie...
AbbVie’s Acquisition of ImmunoGen
Wachtell, Lipton, Rosen & Katz served as legal advisor to AbbVie, while Ropes & Gray served as legal advisor to ImmunoGen. AbbVie Inc. (NYSE: ABBV) and...
In Re: National Prescription Opiate Litigation
Robbins Geller Rudman & Dowd, Seeger Weiss Newark, Plevin & Gallucci, Bertram & Graf, Irpino, Avin & Hawkins, Powell & Majestro, Dugan Law Firm, Cooper Law...